News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Kaldor Stephen W
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/02/2020 |
3
| Kaldor Stephen W (Director) has filed a Form 3 on Kinnate Biopharma Inc. |
| 06/22/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/25/2019 |
4
| Kaldor Stephen W (Director) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Granted 12,500 options to buy
@ $23.24, valued at
$290.5k
|
|
| 07/17/2018 |
3
| Kaldor Stephen W (Director) has filed a Form 3 on Crinetics Pharmaceuticals, Inc. |
| 07/07/2014 |
4
| Kaldor Stephen W (Director) has filed a Form 4 on Furiex Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 7,160 shares
@ $0
Disposed/sold 5,012 options to buy
@ $13.94, valued at
$69.9k
Disposed/sold 8,825 options to buy
@ $13.45, valued at
$118.7k
Disposed/sold 17,500 options to buy
@ $18.22, valued at
$318.9k
|
|
| 03/04/2014 |
4
| Kaldor Stephen W (Director) has filed a Form 4 on Furiex Pharmaceuticals, Inc.|
Txns:
| Granted 3,580 shares
@ $0 |
|
| 05/29/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/14/2013 |
4/A
| Kaldor Stephen W (Director) has filed a Form 4 on Furiex Pharmaceuticals, Inc.|
Txns:
| Sold 5,379 shares
@ $41.74, valued at
$224.5k
Sold 973 shares
@ $40.71, valued at
$39.6k
Sold 1,648 shares
@ $39.96, valued at
$65.9k
Exercised 5,379 options to buy
@ $13.94, valued at
$75k
Exercised 973 options to buy
@ $13.94, valued at
$13.6k
Exercised 1,648 options to buy
@ $13.94, valued at
$23k
Sold 5,379 shares
@ $41.74, valued at
$224.5k
Sold 973 shares
@ $40.71, valued at
$39.6k
Sold 1,648 shares
@ $39.96, valued at
$65.9k
Exercised 5,379 options to buy
@ $13.94, valued at
$75k
Exercised 973 options to buy
@ $13.94, valued at
$13.6k
|
|
| 03/13/2013 |
4
| Kaldor Stephen W (Director) has filed a Form 4 on Furiex Pharmaceuticals, Inc.|
Txns:
| Sold 5,379 shares
@ $41.74, valued at
$224.5k
Sold 973 shares
@ $40.71, valued at
$39.6k
Exercised 8,000 options to buy
@ $13.94, valued at
$111.5k
|
|
| 05/29/2012 |
4
| Kaldor Stephen W (Director) has filed a Form 4 on Furiex Pharmaceuticals, Inc.|
Txns:
| Granted 17,500 options to buy
@ $18.22, valued at
$318.9k
|
|
| 12/07/2011 |
4/A
| Kaldor Stephen W (Director) has filed a Form 4 on Furiex Pharmaceuticals, Inc.|
Txns:
| Granted 8,825 options to buy
@ $13.45, valued at
$118.7k
|
|
| 10/14/2011 |
4
| Kaldor Stephen W (Director) has filed a Form 4 on Furiex Pharmaceuticals, Inc.|
Txns:
| Granted 8,825 options to buy
@ $13.45, valued at
$118.7k
|
|
| 05/23/2011 |
4
| Kaldor Stephen W (Director) has filed a Form 4 on Furiex Pharmaceuticals, Inc.|
Txns:
| Granted 13,012 options to buy
@ $13.94, valued at
$181.4k
|
|
| 12/10/2010 |
3
| Kaldor Stephen W (Director) has filed a Form 3 on Furiex Pharmaceuticals, Inc. |
|
|